{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n Although none of the provided abstracts detail CT47A1 specifically, they offer important context for its function as a member of the cancer/testis (CT) antigen family. Under normal conditions, CT antigens like CT47A1 are expressed only in germ cells; however, they become aberrantly activated in various cancers. In estrogen receptor‐negative breast lesions—including ductal carcinoma in situ—upregulation of CT antigens is associated with aggressive tumor behavior and a pronounced immune response, highlighting their role in cancer immunogenicity."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Likewise, investigations in prostate cancer have demonstrated that several CT antigens can elicit elevated autoantibody responses, supporting their potential as diagnostic and immunotherapeutic biomarkers."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": " In this context, CT47A1 is expected to contribute similarly, serving as a promising target for antibody‐based therapies and cancer detection strategies.\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Furthermore, large‐scale transcriptomic studies, such as those compiled in the CHESS database, expand our understanding of the broader gene expression landscape—including that of CT antigens—in human tissues and cancers."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": " Finally, genomic and clinical profiling in breast cancer survivors indicates that genes with CT antigen characteristics may help predict treatment responses and survivability, thereby opening avenues for personalized therapeutic strategies."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": " \n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Overall, CT47A1 is likely to share these common functional attributes: its aberrant reactivation in cancers may drive tumor progression and stimulate immune responses, positioning it as a valuable biomarker for cancer diagnosis and a potential target for immunotherapy.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Otavia L Caballero, Sami Shousha, Qi Zhao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of Cancer/Testis genes in ductal carcinoma in situ and benign lesions of the breast."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncoscience (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncoscience.4"}], "href": "https://doi.org/10.18632/oncoscience.4"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25593980"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25593980"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Henry A Adeola, Muneerah Smith, Lisa Kaestner, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Novel potential serological prostate cancer biomarkers using CT100+ cancer antigen microarray platform in a multi-cultural South African cohort."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.7359"}], "href": "https://doi.org/10.18632/oncotarget.7359"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26885621"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26885621"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Mihaela Pertea, Alaina Shumate, Geo Pertea, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CHESS: a new human gene catalog curated from thousands of large-scale RNA sequencing experiments reveals extensive transcriptional noise."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genome Biol (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s13059-018-1590-2"}], "href": "https://doi.org/10.1186/s13059-018-1590-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30486838"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30486838"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Ashraf Abou Tabl, Abedalrhman Alkhateeb, Waguih ElMaraghy, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A Machine Learning Approach for Identifying Gene Biomarkers Guiding the Treatment of Breast Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Front Genet (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3389/fgene.2019.00256"}], "href": "https://doi.org/10.3389/fgene.2019.00256"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30972106"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30972106"}]}]}]}